U.S. House · 119th Congress · H.R. 679
H.R. 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Diana HarshbargerR-TN-1
- Introduced
- January 23, 2025, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (18)
18 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Brian BabinR-TX-36
- James R. BairdR-IN-4
- Andy BiggsR-AZ-5
- Mike BostR-IL-12
- Randy FeenstraR-IA-4
- Michael GuestR-MS-3
- Kevin HernR-OK-1
- Clay HigginsR-LA-3
- Mary E. MillerR-IL-15
- John R. MoolenaarR-MI-2
- Gary J. PalmerR-AL-6
- Randy K. Weber, Sr.R-TX-14
- Daniel WebsterR-FL-11
- Rudy Yakym IIIR-IN-2
Signed on later
- Andy HarrisR-MD-1January 28, 2025
- Keith SelfR-TX-3February 4, 2025
- Sheri BiggsR-SC-3March 31, 2025
- Mark B. MessmerR-IN-8February 4, 2026